UK markets close in 6 hours 59 minutes

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
6.450.00 (0.00%)
At close: 04:00PM EDT
6.78 +0.33 (+5.12%)
After hours: 04:48PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,290
1
60
249
539
Cost of revenue
0
-
0
199
472
Gross profit
1,290
-
60
50
67
Operating expenses
Research development
4,291
1,913
4,758
5,692
5,916
Selling general and administrative
6,393
5,548
6,034
4,989
5,801
Total operating expenses
11,403
7,278
10,295
9,404
7,418
Operating income or loss
-10,113
-7,277
-10,235
-9,354
-7,351
Interest expense
-
-
-
-
769
Total other income/expenses net
-96
1,703
-24
577
713
Income before tax
-10,180
-5,569
-10,206
-8,776
-7,407
Income from continuing operations
-10,180
-5,569
-10,206
-8,776
-7,407
Net income
-10,180
-5,569
-10,206
-8,776
-18,242
Net income available to common shareholders
-10,180
-5,569
-10,206
-8,776
-18,242
Basic EPS
-8.20
-7.41
-15.19
-18.00
-96.60
Diluted EPS
-8.20
-7.41
-15.19
-18.00
-96.60
Basic average shares
746.138
752
672
486.5
188.65
Diluted average shares
746.138
752
672
486.5
188.65